Bioverativ
Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.
Currently, there are no issues on this topic.
Find more companies like Bioverativ
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
